Oncology Supportive Care
Artelo Biosciences Limited focuses on clinical research in cancer anorexia and weight loss, with interest in therapies that address appetite decline and nutritional deterioration in people living with cancer.
- Cancer anorexia
- Weight loss
- Supportive oncology
The sponsor’s research activity is centered on treatment areas linked to appetite stimulation, lean body mass, and functional status in oncology populations.
Body Composition and Nutritional Status
Its clinical interests include outcomes related to lean body mass and weight gain, reflecting a therapeutic focus on preserving physical condition in patients affected by cancer-associated wasting.
- Lean body mass
- Weight gain
- Cancer-associated wasting
These areas highlight attention to nutritional and metabolic consequences of cancer that can influence daily functioning and overall well-being.
Functional Performance in Cancer Care
Research activity also extends to Karnofsky Performance Status, indicating an interest in clinical measures of physical capability and patient functioning alongside symptom control.
- Karnofsky Performance Status
- Functional status
- Patient well-being
This area connects appetite and weight-related outcomes with broader measures of how cancer symptoms affect everyday activity.
Cannabinoid-Based Therapeutics
The sponsor’s trial portfolio includes investigation of a synthetic cannabinoid in oncology settings, placing emphasis on cannabinoid-based approaches for symptom management in cancer-related conditions.
- Synthetic cannabinoid
- Appetite-related symptoms
- Oncology symptom management
This therapeutic area aligns with clinical interest in agents designed to address the metabolic and appetite consequences associated with cancer.
